Product Information
BENICAR 5 MG TABLET is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $10.1271 per EA under NDC 00713086030. Its NADAC has been published 119 times since Apr 17, 2024.
FDA first approved this application on Apr 25, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the olmesartan medoxomil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713086030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/1/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
New Drug (NDA)
FDA Application
NDA021286FDA Approved
4/25/2002
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BENICAR 5 MG TABLET has been published 119 times since Apr 17, 2024, and over the history we have for it it has risen 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1271 per EA |
|---|---|
| All-time high | $10.1271 (Jul 22, 2026) |
| All-time low | $7.6535 (Apr 17, 2024) |
| 52-week high | $10.1271 |
| 52-week low | $8.4033 |
| Median price | $8.4335 |
| Average price | $8.5845 |
| Largest weekly change | +10.0% (Sep 25, 2024) |
| Weeks tracked | 119 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
+9.9%
6M
+11.0%
1Y
+20.5%
3Y
N/A
5Y
N/A
All
+32.3%
Last surveyed Jul 22, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENICAR 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENICAR 5 MG TABLET, manufactured by Cosette Pharmaceuticals, Inc., is $10.1271 per EA (NDC 00713086030), effective Jul 22, 2026.
How has the price of BENICAR 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENICAR 5 MG TABLET has risen 32.3%. It has been tracked across 119 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BENICAR 5 MG TABLET?
Since Apr 17, 2024, the NADAC for BENICAR 5 MG TABLET has ranged from a low of $7.6535 (Apr 17, 2024) to a high of $10.1271 (Jul 22, 2026), with a median of $8.4335 per EA.
Are there cheaper alternatives to BENICAR 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 5 MG TAB, is $0.0551 per EA — about 99% below BENICAR 5 MG TABLET.
Who manufactures BENICAR 5 MG TABLET?
BENICAR 5 MG TABLET (NDC 00713086030) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.